Showing results (71-80 of 100) with videos related to
Sort By:
Pageof 10
Contemporary Clinical Trials|July 19, 2011
The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney diseaseD Fliser, F Dellanna, M Koch, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 29, 2000
Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosisS M Bode-Böger, R H Böger, J T Kielstein, et al.Lupus|November 17, 2010
Elevation of serum CXCL13 in SLE as well as in sepsisL Schiffer, J T Kielstein, M Haubitz, et al.European Journal of Clinical Pharmacology|June 24, 1999
Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchangedD Fliser, I Bischoff, A Hanses, et al.Journal of Hypertension|March 1, 1997
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onsetD Fliser, C Keller, P Bahrmann, et al.Kidney International|February 13, 1999
Coadministration of albumin and furosemide in patients with the nephrotic syndromeD Fliser, I Zurbrüggen, E Mutschler, et al.Clinical Toxicology (Philadelphia, Pa.)|August 19, 2014
Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroupS Gosselin, D N Juurlink, J T Kielstein, et al.Journal of Medical Case Reports|October 4, 2021
Melkersson-Rosenthal syndrome in the context of sarcoidosis: a case reportJ Casper, S Mohammad-Khani, J J Schmidt, et al.International Journal of Clinical Practice|November 25, 2010
Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL studyF Dellanna, R E Winkler, F Bozkurt, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1997
Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humansD Fliser, E Franek, P Fode, et al.Pageof 10